Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;42(9):1398-400.
doi: 10.1016/j.biocel.2010.05.010. Epub 2010 Jun 4.

Aging, antagonistic pleiotropy and fibrotic disease

Victor J Thannickal  1
Affiliations

Aging, antagonistic pleiotropy and fibrotic disease

Victor J Thannickal. Int J Biochem Cell Biol. 2010 Sep.

Abstract

Tissue fibrosis is most often referred to in its pathological context and is a major cause of progressive organ failure and death. Here, we consider fibrosis as an evolutionarily conserved, adaptive tissue response to injury. The role of NADPH oxidase 4 (Nox4) as a novel pro-fibrogenic mediator is highlighted. The concept that Nox4 may function as an antagonistically pleiotropic gene in age-associated fibrotic disorders is discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The proposed role of Nox4 in myofibroblast differentiation/activation and factors that influence alveolar epithelial cell injury-repair
Injury to the alveolar epithelium is typically accompanied by a regenerative response involving the differentiation of “cuboidal” alveolar type II cells to “squamous” alveolar type I cells that constitute >95% of the alveolar surface lining. This regenerative response is facilitated by a provisional extracellular matrix elaborated by tissue-resident mesenchymal cells. Myofibroblasts are a distinct subpopulation of mesenchymal cells with contractile properties and that differentiate in response to transforming growth factor-β1 (TGF-β1)-induced activation of NADPH oxidase isoform 4 (Nox4). Apoptosis and clearance of myofibroblasts facilitate the resolution of the repair process, leading to restitution of normal alveolar structure/function. The persistence of activated myofibroblasts (due to the acquisition of apoptosis-resistant and/or proliferative phenotypes) leads to progressive fibrosis that characterizes a number of human fibrotic diseases, including idiopathic pulmonary fibrosis. The inability to “deactivate” myofibroblasts may be related to a number of host (age, epigenetic and genetic factors) and environmental factors. Age may also influence the susceptibility of the alveolar epithelium to injury/apoptosis, thus impairing normal alveolar regeneration.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, Phillips JA, 3rd, Lansdorp PM, Loyd JE, Armanios MY. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 2008;105:13051–13056. - PMC - PubMed
    1. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet. 2009;10:45–61. - PMC - PubMed
    1. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;178:729–737. - PMC - PubMed
    1. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med. 2009;15:1077–1081. - PMC - PubMed
    1. Kawahara T, Quinn MT, Lambeth JD. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol Biol. 2007;7:109. - PMC - PubMed

Publication types